Our September 2019 newsletter includes information about the MASTER-GC Study and the Pharmacokinetics Special Emphasis Panel. We also provide a spotlight on early-career trialist, Thomas L. Holland, MD, MSc of Duke University. ARLG’s presence at IDWeek2019 is included as well as ... Read more from this Newsletter
Read the April 2019 newsletter to learn more about the Multi-Drug Resistant Organism (MDRO) Network site visits in accordance with the National Institutes of Health (NIH) regulatory compliance requirements. The newsletter features an update from Kim Hanson, MD, MHS, Chairperson ... Read more from this Newsletter
Our January 2019 newsletter provides highlights from ARLG at IDWeek 2018TM, held October 3rd-7th in San Francisco, CA. ARLG leaders, researchers, or committee members moderated panels and presented lectures, posters, or abstracts at close to 300 sessions.
In this issue, you can learn more about Sarah Doernberg, MD, ... Read more from this Newsletter
Check out our September 2018 newsletter for our latest fact sheets and lay summaries of results for the RADICAL and PROOF studies.
In this issue, we interview Yohei Doi, MD, PhD, chair of the Gram-negative Committee who provides his thoughts and insights ... Read more from this Newsletter
The June 2018 newsletter features highlights from our Multi-Drug Resistance Organism (MDRO) global network meeting in Madrid, Spain, as well as an update from the ARLG Mentoring Program.
We also profile ARLG Research Fellow Judith Anesi, MD, and two Early Stage Investigator Grant recipients, Michael A. ... Read more from this Newsletter
Our March 2018 newsletter shares updates from the 2018 ARLG Operations Retreat, as well as highlights the ARLG Special Populations Special Emphasis Panel and the Pediatrics Subcommittee.
You can also learn more about Ritu Banerjee, MD, PhD, who along with other ARLG investigators developed the Rapid Identification ... Read more from this Newsletter